scispace - formally typeset
K

Kay H. Wilkinson

Researcher at The Royal Marsden NHS Foundation Trust

Publications -  15
Citations -  3942

Kay H. Wilkinson is an academic researcher from The Royal Marsden NHS Foundation Trust. The author has contributed to research in topics: Ulcerative colitis & Colorectal cancer. The author has an hindex of 12, co-authored 15 publications receiving 3726 citations.

Papers
More filters
Journal ArticleDOI

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

TL;DR: In long-standing extensive ulcerative colitis, the severity of colonic inflammation is an important determinant of the risk of colorectal neoplasia and endoscopic and histological grading of inflammation could allow better risk stratification for surveillance programs.
Journal ArticleDOI

Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis

TL;DR: Although two thirds of patients with potentially life-threatening neoplasia benefited from surveillance, the program was not wholly effective in cancer prevention, suggesting there is no need to intensify surveillance over time.
Journal ArticleDOI

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis

TL;DR: Surveillance identified some patients at a curable stage of cancer or with dysplasia, andLimiting factors were failure to include patients with presumed distal colitis, biennial colonoscopy, the number of biopsy specimens at each colonoscopic, and variation in histological identification and grading of Dysplasia.
Journal ArticleDOI

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk

TL;DR: Macroscopic colonoscopic features help predict neoplasia risk in UC and it should be possible to reduce surveillance frequency to five years in this cohort.
Journal Article

Matrix Metalloprotease 2 (MMP-2) and Matrix Metalloprotease 9 (MMP-9) Type IV Collagenases in Colorectal Cancer

TL;DR: MMP-2 is controlled at the level of mRNA and protein production and activation in colorectal cancer, and active M MP-2 and MMP-9 enzymes are associated strongly with Dukes' A and C stages of the disease.